Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells

Xiaoming Jiang, Yulian Xu, Mu‐Yang Huang, +4

Acta Pharmacologica Sinica

Tumor BiologyMedicineCell DeathBronchial NeoplasmCancer Biology +8

Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells

Mu‐Yang Huang, Xiaoming Jiang, Yulian Xu, +8

Food and Chemical Toxicology

Tumor BiologyPlatycodin DOncogenic AgentMedicineApoptosis +10

Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10

Mu‐Yang Huang

Pharmacological Research

Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells

Luo‐Wei Yuan, Xiaoming Jiang, Yulian Xu, +8

Phytomedicine

Oncogenic AgentMedicineImmunologyCell DeathImmune Checkpoint Inhibitor +9

Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells

Yu‐Chi Chen, Xinling He, Qi Lu, +8

Biochemical Pharmacology

Tumor BiologyIdo1 ExpressionCancer ImmunosurveillanceLung InflammationMedicine +10

Regulation of CD47 expression by interferon-gamma in cancer cells

Zi-Han Ye, Xiaoming Jiang, Mu‐Yang Huang, +7

Translational Oncology

Nagilactone E suppresses TGF-β1-induced epithelial–mesenchymal transition, migration and invasion in non-small cell lung cancer cells

Lele Zhang, Xiaoming Jiang, Mu‐Yang Huang, +7

Phytomedicine

Tumor BiologyOncologyLung InflammationMedicineCancer Cell Biology +11

c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2

Min‐Xia Su, Yulian Xu, Xiaoming Jiang, +7

Acta Pharmaceutica Sinica B

Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells

Yu‐Chi Chen, Mu‐Yang Huang, Lele Zhang, +10

Chinese Journal of Natural Medicines

Pd-l1 ExpressionOncogenic AgentMedicineImmunologyCell Death +10

Glutathione peroxidase 8 expression on cancer cells and cancer‐associated fibroblasts facilitates lung cancer metastasis

Yulian Xu, Luo‐Wei Yuan, Xiaoming Jiang, +7

MedComm